HomeCompareCRAWA vs JNJ

CRAWA vs JNJ: Dividend Comparison 2026

CRAWA yields 2.43% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $7.2K in total portfolio value· pulled ahead in Year 8
10 years
CRAWA
CRAWA
● Live price
2.43%
Share price
$82.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.3K
Annual income
$283.77
Full CRAWA calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CRAWA vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRAWAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRAWA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRAWA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRAWA
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$241.20/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,796.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRAWA + JNJ for your $10,000?

CRAWA: 50%JNJ: 50%
100% JNJ50/50100% CRAWA
Portfolio after 10yr
$26.9K
Annual income
$2,516.83/yr
Blended yield
9.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CRAWA
No analyst data
Altman Z
5.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRAWA buys
0
JNJ buys
0
No recent congressional trades found for CRAWA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRAWAJNJ
Forward yield2.43%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$23.3K$30.5K
Annual income after 10y$283.77$4,749.88
Total dividends collected$2.6K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRAWA vs JNJ ($10,000, DRIP)

YearCRAWA PortfolioCRAWA Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,943$242.62$10,594$274.49+$349.00CRAWA
2$11,957$248.13$11,294$360.69+$663.00CRAWA
3$13,047$253.38$12,133$476.91+$914.00CRAWA
4$14,219$258.40$13,156$635.42+$1.1KCRAWA
5$15,477$263.19$14,432$854.61+$1.0KCRAWA
6$16,828$267.74$16,056$1,162.76+$772.00CRAWA
7$18,278$272.07$18,175$1,604.53+$103.00CRAWA
8← crossover$19,834$276.18$21,009$2,252.68$1.2KJNJ
9$21,503$280.08$24,911$3,229.73$3.4KJNJ
10$23,292$283.77$30,458$4,749.88$7.2KJNJ

CRAWA vs JNJ: Complete Analysis 2026

CRAWAStock

Crawford United Corporation, together with its subsidiaries, provides specialty industrial products and solutions in the United States, Puerto Rico, Mexico, Canada, and internationally. It operates through two segments, Commercial Air Handling Equipment, and Industrial and Transportation Products. The Commercial Air Handling segment designs, manufactures, and installs large-scale commercial, institutional, and industrial custom air handling solutions to health care, education, pharmaceutical, and industrial manufacturing markets under the FactoryBilt and SiteBilt brand names. The Industrial and Transportation Products segment is involved in the manufacture of flexible interlocking metal hoses primarily to heavy-duty truck manufacturers and aftermarket suppliers, as well as to the agricultural, industrial, and petrochemical markets; and distribution of silicone and hydraulic hoses to the agriculture and general industrial markets. The company also provides engineering, machining, grinding, welding, brazing, heat treat, and assembly solutions; rubber and plastic marine hose for the recreational boating industry; engineered manufacturing solutions, including CNC machining, anodizing, electro polishing, and laser marking for defense, aerospace, and medical device markets; and hydraulic hoses, air tank assemblies, and related products to manufacturers of firefighting trucks and other emergency vehicles. In addition, it engages in the supply of highly engineered forgings for the aerospace, industrial gas turbine, medical prosthetics, alternative energy, petrochemical, and defense industries; and developing and commercializing marketing and data analytic technology applications. The company was formerly known as Hickok Incorporated and changed its name to Crawford United Corporation in May 2019. Crawford United Corporation was founded in 1910 and is headquartered in Cleveland, Ohio.

Full CRAWA Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CRAWA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRAWA vs SCHDCRAWA vs JEPICRAWA vs OCRAWA vs KOCRAWA vs MAINCRAWA vs ABBVCRAWA vs MRKCRAWA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.